Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9844.
-
Ouster Q3 2026 Earnings Call TranscriptOuster (NASDAQ:OUST) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
-
Huron Consulting Group Reports Q3 2026 Financial ResultsHuron Consulting Group announced its third-quarter 2026 financial results, reporting revenue of $491.5 million and non-GAAP earnings per share that exceeded analyst expectations.
-
Tidewater Announces Earnings Release and Conference CallTidewater Inc. has scheduled the release of its financial results for the third quarter ending September 30, 2026, for November 9, 2026.
-
Eagle Materials Declares Quarterly DividendEagle Materials Inc. has declared a quarterly cash dividend of $0.25 per share, payable in January 2027.
-
Wedbush Adjusts Price Target on Beam TherapeuticsWedbush maintained an Outperform rating on Beam Therapeutics while raising its price target to $30 from $28.
-
PACS Group, Inc. Reports Third Quarter 2026 Financial ResultsPACS Group, Inc. announced its financial results for the third quarter of 2026, reporting $1.50 billion in revenue and raising its full-year 2026 revenue guidance.
-
CF Industries Holdings, Inc. Analyst Rating Maintained by Freedom BrokerFreedom Broker has maintained a 'Hold' rating on CF Industries Holdings, Inc. as the company prepares to report its third-quarter 2026 financial results.
-
Citigroup Maintains Neutral Rating on Cactus, Inc. and Raises Price TargetCitigroup has updated its outlook on Cactus, Inc., maintaining a 'Neutral' rating while increasing the price target from $73 to $74.
-
Alamar Biosciences Updates 2026 Revenue GuidanceAlamar Biosciences expects full-year 2026 revenue to be in the range of $121 million to $123 million, surpassing the FactSet estimate of $118.6 million.
-
Alamar Biosciences Reports Q3 2026 RevenueAlamar Biosciences reported Q3 2026 revenue of $33.5 million, exceeding the FactSet consensus estimate of $30.2 million.
-
Alamar Biosciences Announces Strategic Scientific Collaboration with GSKAlamar Biosciences and GSK have entered a strategic scientific collaboration to utilize Alamar's NULISA platform for a large-scale study on protein biomarkers.
-
Jackson Financial Inc. Reports Q3 2026 Financial ResultsJackson Financial Inc. reported third-quarter 2026 financial results, exceeding analyst expectations for adjusted earnings per share.
-
Fairfax India Holdings Corporation Reports Third Quarter 2026 Financial ResultsFairfax India announced net earnings of $37.6 million for the third quarter of 2026, compared to $3.2 million in the same period of 2025.
-
Flywire Corporation Reports Third Quarter 2026 Financial ResultsFlywire Corporation announced its financial results for the third quarter ended September 30, 2026, reporting strong top-line growth and expanded adjusted EBITDA margins.
-
Procore Technologies Reports Q3 2026 Financial Results and Sets Q4 GuidanceProcore Technologies, Inc. reported third-quarter 2026 financial results, exceeding analyst estimates for both revenue and adjusted earnings per share, while providing guidance for the fourth quarter.
-
Curaleaf Evaluates Aurora Cannabis's Alternative Transaction with OrganigramCuraleaf Holdings, Inc. is reviewing the proposed merger between Aurora Cannabis and Organigram while maintaining its own outstanding offer for Aurora.
-
National Energy Services Reunited Corp. Schedules Q3 2026 Earnings AnnouncementNational Energy Services Reunited Corp. (NESR) has scheduled the release of its financial results for the third quarter of 2026 for November 4, 2026.
-
Curaleaf Reports Third Quarter 2026 Financial ResultsCuraleaf Holdings, Inc. announced its financial and operating results for the third quarter ended September 30, 2026, highlighting record revenue and robust profitability.
-
Toast, Inc. Reports Q3 2026 Financial ResultsToast, Inc. reported third-quarter 2026 financial results, exceeding analyst expectations for both revenue and earnings per share.
-
American International Group, Inc. Reports Q3 2026 Financial ResultsAIG reported third-quarter 2026 adjusted earnings per share of $2.06, exceeding analyst expectations of $1.88.